Forlaks powder for solution inside the pack 10d. 20 pc

$6.86

Forlaks powder for solution inside the pack 10d. 20 pc

Quantity:

SKU: 0723160494 Categories: , , Tag:

Description

Composition
Active substance:
Macrogol 4000 – 10.00 g
Excipients:
: Orange flavor, grapefruit * – 0.15 g
Sodium saccharin – 0.017 g * Orange oil, grapefruit oil, orange juice concentrate, citral, acetaldehyde, linalol, ethyl butyrate, alpha terpineol, octanal, cis-3-hexenol, maltodextrin, acacia gum, sorbitol (E420), sulfur dioxide ( E220), butylhydroxyanisole (E320).
Description:
The powder is white or almost white smell from orange and grapefruit, readily soluble in water to form a white translucent solution.
Product form:
powder for solution for intake 10 g.
By 10.167 g in packages made of paper laminated with aluminum foil and polyethylene.
10 or 20 a package together with instructions for use placed in a cardboard box.
Contraindications
– severe inflammatory bowel disease (ulcerative colitis, Crohn’s disease) or toxic colon expansion, combined with symptomatic stenosis; – perforation of the threat or perforation of the gastrointestinal tract; – ileus or suspicion of intestinal obstruction; – abdominal pain of unknown etiology; – hypersensitivity to macrogol (polyethylene glycol) or any of the components; – Children under 8 years old.
Dosage
10 g
Indications
Symptomatic treatment of constipation in adults and children from 8 years and older.
Interaction with other drugs
Not described. May slow the absorption of drugs taken at the same time forlaks. Therefore, it is recommended to appoint Forlaks® later, at least 2 hours after administration of other drugs.
Overdose
An overdose of the drug leads to diarrhea, followed by the disappearance after dose reduction or treatment discontinuation.
Excessive fluid loss from diarrhea or vomiting may require correction of electrolyte disturbances.
pharmachologic effect
Pharmacological group:
Laxative.
Pharmacodynamics:
Large molecular weight of macrogol 4000 due to the long linear polymers which retain water molecules by means of hydrogen bonds.
Due to this, after oral administration increases the amount of intestinal contents.
The volume of unabsorbed fluid in the lumen of the intestine, supports a laxative effect solution.
Pharmacokinetics:
The pharmacokinetic data confirm that macrogol 4000 is not subject to any gastrointestinal resorption nor biotransformation after oral administration.
Pregnancy and breast-feeding
Pregnancy
Results from animal studies have shown that Macrogol 4000 is not teratogenic.
Since systemic exposure to the drug Forlaks® is small, negative impact on the mother’s body and the fetus is expected. Forlaks® can be taken during pregnancy.
Lactation
Systemic exposure of macrogol 4000 in the body lactating women is negligible, so the negative effects on the body of the newborn / infant is not expected. Forlaks® can be taken during lactation.
Conditions of supply of pharmacies
Without a prescription.
side effects
In adults.
Side effects observed in clinical trials in 600 patients who had transient observed with the following frequency and concern mainly the gastrointestinal tract: – frequent side effects (more than 1/100, less than 1/10) bloating and / or pain, nausea, diarrhea; – rare side effects (more than 1/1000, less than 1/100): vomiting, urge to defecate urgency and fecal incontinence.
Additional information derived from post-marketing observations included: very rarely (less than 1/10000) cases of hypersensitivity: pruritus, urticaria, transient (transient) rash, facial swelling, angioedema and sporadic cases of anaphylactic shock.
Unknown frequency of diarrhea, leading to breakdown of electrolyte balance (hyponatremia, hypokalemia) and / or dehydration, particularly in adult patients.
In children.
Side effects related to the gastrointestinal tract, were minimal and were transient in nature in clinical studies involving 147 children aged 6 months to 15 years, were detected at the following rates:
Disorders of the gastrointestinal tract: – frequent side effects (more than 1/100, less than 1/10): diarrhea, abdominal pain, – rare side effects (more than 1/1000, less than 1/100): flatulence, nausea and vomiting. – side effects that can not be estimated from available data: hypersensitivity reactions.
Diarrhea may be a cause of pain in the perianal area.
special instructions
Organic disorders of the gastrointestinal tract should be excluded prior to initiating therapy.
Warning.
constipation treatment with drugs recommended only as an aid to healthy lifestyle and diet, for example: – increase in fluid and fiber consumption, – adequate physical activity that contributes to the restoration of gastrointestinal motility.
In the case of diarrhea with extreme caution should treat patients prone to disruption of water-electrolyte balance (e.g., in the elderly, patients with impaired liver or renal function, or patients taking diuretics) and electrolyte control should be carried out. Forlaks® not contain substantial amounts of carbohydrate and / or polyols (sugar alcohols) and can be used in patients with diabetes or in patients who are excluded from the diet galactose.
It has been reported very rare cases of hypersensitivity (including rash, hives, swelling) upon receipt of preparations containing macrogol (polyethylene glycol). In exceptional cases, anaphylactic shock was observed.
Because of the presence of sorbitol, patients with congenital fructose intolerance should not take this drug.
Due to the presence of sulfur dioxide in rare cases may cause serious allergic reactions and bronchospasm.
It reported cases of aspiration, when a large amount of macrogol and electrolytes administered via a nasogastric tube.
Children with neurological disorders that have a swallowing disorder are at risk of aspiration.
IMPACT ON drive vehicles and management mechanisms
It does not affect the ability to drive vehicles and mechanisms.
Storage conditions
At a temperature of not higher than 30 ° C, the reach of children.
Dosing and Administration
Inside, the contents 1 – 2 packets (preferably as a single dose in the morning) or 1 packet (morning and evening) in case of reception of packets 2 per day.
The daily dosage should be adapted according to the clinical effect and can vary from one packet every day (particularly in children), up to 2 packs per day.
The contents of each packet to be dissolved in a glass of water immediately before administration.
The effect of receiving Forlaksa® expressed within 24 – 48 hours after ingestion.
The recommended course of treatment for children and adults – 3 months.
In children, treatment should not exceed 3 months due to the lack of clinical data.
Maintenance of effect after the restoration of normal functioning of the intestines should be carried out with the help of an active lifestyle and a diet rich in plant fiber.
If constipation symptoms persist for more than 3 months, it is necessary to re extended diagnostic tests.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

Ipsen

There are no reviews yet.

Add your review